SMO ClinPlus Co. Ltd. (301257) — Cash Flow Reinvestment Rate
SMO ClinPlus Co. Ltd. (301257) has a Cash Flow Reinvestment Rate of 2.87x as of December 2025, reinvesting CN¥102.61 Million (capex CN¥7.83 Million plus investments CN¥94.78 Million) from operating cash flow of CN¥35.69 Million. Check SMO ClinPlus Co. Ltd. earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
SMO ClinPlus Co. Ltd. Cash Flow Reinvestment Rate (2019–2025)
Historical reinvestment intensity for SMO ClinPlus Co. Ltd. across 6 annual periods. Explore 301257 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for SMO ClinPlus Co. Ltd. (2019–2025)
Year-by-year capital reinvestment analysis for SMO ClinPlus Co. Ltd.. For live market cap and broader valuation context, see SMO ClinPlus Co. Ltd. market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.87x | CN¥102.61 Million | CN¥35.69 Million | CN¥7.83 Million | ▲ +12.0% |
| 2023 | 2.57x | CN¥294.70 Million | CN¥114.85 Million | CN¥10.25 Million | ▼ -30.9% |
| 2022 | 3.71x | CN¥150.07 Million | CN¥40.44 Million | CN¥7.95 Million | ▲ +1653.2% |
| 2021 | 0.21x | CN¥8.79 Million | CN¥41.52 Million | CN¥4.40 Million | ▼ -41.7% |
| 2020 | 0.36x | CN¥8.15 Million | CN¥22.45 Million | CN¥4.08 Million | ▼ -1.7% |
| 2019 | 0.37x | CN¥16.82 Million | CN¥45.53 Million | CN¥4.91 Million | — |